Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1974 3
1975 1
1976 3
1977 6
1978 10
1979 4
1980 4
1981 3
1982 3
1983 3
1984 1
1985 1
1986 1
1987 1
1988 3
1989 3
1990 6
1991 5
1992 6
1993 1
1994 4
1995 4
1996 1
1997 6
1998 7
1999 9
2000 12
2001 4
2002 4
2003 7
2004 9
2005 5
2006 6
2007 5
2008 4
2009 3
2010 7
2011 9
2012 6
2013 4
2014 8
2015 11
2016 6
2017 12
2018 8
2019 23
2020 12
2021 18
2022 17
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Results by year

Filters applied: . Clear all
Page 1
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Mirza MR, Åvall Lundqvist E, Birrer MJ, dePont Christensen R, Nyvang GB, Malander S, Anttila M, Werner TL, Lund B, Lindahl G, Hietanen S, Peen U, Dimoula M, Roed H, Ør Knudsen A, Staff S, Krog Vistisen A, Bjørge L, Mäenpää JU; AVANOVA investigators. Mirza MR, et al. Among authors: anttila m. Lancet Oncol. 2019 Oct;20(10):1409-1419. doi: 10.1016/S1470-2045(19)30515-7. Epub 2019 Aug 29. Lancet Oncol. 2019. PMID: 31474354 Clinical Trial.
Hyaluronan in human malignancies.
Sironen RK, Tammi M, Tammi R, Auvinen PK, Anttila M, Kosma VM. Sironen RK, et al. Among authors: anttila m. Exp Cell Res. 2011 Feb 15;317(4):383-91. doi: 10.1016/j.yexcr.2010.11.017. Epub 2010 Dec 3. Exp Cell Res. 2011. PMID: 21134368 Review.
Pharmacokinetics of toremifene.
Anttila M, Valavaara R, Kivinen S, Mäenpää J. Anttila M, et al. J Steroid Biochem. 1990 Jun 22;36(3):249-52. doi: 10.1016/0022-4731(90)90019-o. J Steroid Biochem. 1990. PMID: 2142247
Design and Application of Sensors for Chemical Cytometry.
Vickerman BM, Anttila MM, Petersen BV, Allbritton NL, Lawrence DS. Vickerman BM, et al. Among authors: anttila mm. ACS Chem Biol. 2018 Jul 20;13(7):1741-1751. doi: 10.1021/acschembio.7b01009. Epub 2018 Feb 8. ACS Chem Biol. 2018. PMID: 29376326 Free PMC article. Review.
Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine.
Quixabeira DCA, Jirovec E, Pakola S, Havunen R, Basnet S, Santos JM, Kudling TV, Clubb JHA, Haybout L, Arias V, Grönberg-Vähä-Koskela S, Cervera-Carrascon V, Pasanen A, Anttila M, Tapper J, Kanerva A, Hemminki A. Quixabeira DCA, et al. Among authors: anttila m. Cancer Gene Ther. 2023 Nov;30(11):1543-1553. doi: 10.1038/s41417-023-00658-3. Epub 2023 Sep 4. Cancer Gene Ther. 2023. PMID: 37666898 Free PMC article.
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer.
Quixabeira DCA, Pakola S, Jirovec E, Havunen R, Basnet S, Santos JM, Kudling TV, Clubb JHA, Haybout L, Arias V, Grönberg-Vähä-Koskela S, Cervera-Carrascon V, Kerkelä E, Pasanen A, Anttila M, Tapper J, Kanerva A, Hemminki A. Quixabeira DCA, et al. Among authors: anttila m. Cancer Gene Ther. 2023 Dec;30(12):1679-1690. doi: 10.1038/s41417-023-00674-3. Epub 2023 Nov 10. Cancer Gene Ther. 2023. PMID: 37949944 Free PMC article.
PErsonalized TReatment for Endometrial Carcinoma (PETREC): study design and methods of a prospective Finnish multicenter trial.
Loukovaara M, Bützow R, Staff S, Mäenpää M, Faltinová M, Lassus H, Veijalainen O, Grönvall M, Vaalavirta L, Kuikka E, Haataja M, Urpilainen E, Simojoki M, Anttila M, Auranen A. Loukovaara M, et al. Among authors: anttila m. Int J Gynecol Cancer. 2023 Nov 6;33(11):1807-1811. doi: 10.1136/ijgc-2023-004939. Int J Gynecol Cancer. 2023. PMID: 37813479 Clinical Trial.
Pneumococcal conjugate vaccines.
Eskola J, Anttila M. Eskola J, et al. Among authors: anttila m. Pediatr Infect Dis J. 1999 Jun;18(6):543-51. doi: 10.1097/00006454-199906000-00015. Pediatr Infect Dis J. 1999. PMID: 10391188 Review. No abstract available.
[Ovarian cysts].
Kuivasaari-Pirinen P, Anttila M. Kuivasaari-Pirinen P, et al. Among authors: anttila m. Duodecim. 2011;127(17):1857-63. Duodecim. 2011. PMID: 21995122 Finnish.
An oncolytic adenovirus coding for a variant interleukin 2 cytokine improves response to chemotherapy through enhancement of effector lymphocyte cytotoxicity, fibroblast compartment modulation and mitotic slippage.
Pakola S, Quixabeira DCA, Kudling TV, Clubb JHA, Grönberg-Vähä-Koskela S, Basnet S, Jirovec E, Arias V, Haybout L, Heiniö C, Santos JM, Cervera-Carrascon V, Havunen R, Anttila M, Hemminki A. Pakola S, et al. Among authors: anttila m. Front Immunol. 2023 Jul 5;14:1171083. doi: 10.3389/fimmu.2023.1171083. eCollection 2023. Front Immunol. 2023. PMID: 37475863 Free PMC article.
292 results